This activity is part of a 14-course series designed to equip licensed practitioners from medical, nursing, and related disciplines with a multidisciplinary approach to managing patients with psoriasis.
5. Systemic Biologic Therapies for Psoriasis
Biologics have swept the field of medicine over the last decade and now a wide range of biologic agents are approved for psoriasis. These powerful agents can be life changing for patients with psoriasis but are not for everyone. This activity will review the science behind the different classes of biologics in the treatment of psoriasis.
After completing this activity, participants will able to:
The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:
|Name of Faculty||Reported Financial Relationship|
|Jeffrey Crowley, MD||
Investigator/Consultant/Speaker: AbbVie, Celgene, Janssen, Lilly, Novartis, Regeneron, Sanofi-Aventis, Sun Pharma, UCB
Investigator: Merck, Pfizer, MC2 Therapeutics, Sandoz, Verrica Pharmaceuticals
This activity is jointly provided by SynAptiv and Dermeda
Questions about CE accreditation or CE certificates related to this course, please contact us via email at email@example.com.
Copyright © 2018 Dermveda. All rights reserved. This material may not be reproduced, displayed, modified or distributed without the express prior written permission of the copyright holder.